Skip to content
Pharma Observatory a Scientist.com platform
  • Trial site

Trial site location from the registry's own city and country. GeoNames (geonames.org).

Clinical trial site

Centre Antoine Lacassagne

Centre Antoine Lacassagne in Nice, France is listed as a site for 510 registered clinical trials, 178 of them ongoing.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Registered trials 510
Ongoing 178

This page covers the site record Centre Antoine Lacassagne in Nice, France: the trials that list it by this name in ClinicalTrials.gov. The same place can be registered under other names, each with its own page and its own trials, and a count here is a number of registered trials, not of patients enrolled. The organization of the same name, Centre Antoine Lacassagne, also sponsors trials.

Get the Centre Antoine Lacassagne report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Trials by phase

Registered trials that list this site, by trial phase. 510 trials counted.

  • Phase 1 14 trials
  • Phase 1/2 29 trials
  • Phase 2 156 trials
  • Phase 2/3 9 trials
  • Phase 3 165 trials
  • Phase 4 3 trials
  • Not applicable 85 trials
  • Observational 49 trials

Trials by status

The registry's own status summary: Ongoing, Completed, Terminated or Other.

  • Ongoing 178 trials
  • Completed 243 trials
  • Terminated 56 trials
  • Other 33 trials

Trials over time

Trials registered with a start date in each year, 1990 onward, most recent years first.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 2/3
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational

Top of scale: 32

1993: 4 trials (Phase 3 4) 1994: 2 trials (Phase 3 1, Phase 2 1) 1995: 2 trials (Phase 3 2) 1996: 6 trials (Phase 3 6) 1998: 10 trials (Phase 3 4, Phase 2 6) 1999: 6 trials (Phase 3 5, Phase 2 1) 2001: 2 trials (Phase 2 2) 2002: 7 trials (Phase 3 3, Phase 2 4) 2003: 4 trials (Phase 3 2, Phase 2 1, Phase 1 1) 2004: 5 trials (Phase 3 3, Phase 2 2) 2005: 8 trials (Observational 1, Not applicable 2, Phase 3 1, Phase 2 4) 2006: 6 trials (Not applicable 1, Phase 3 4, Phase 2 1) 2007: 11 trials (Not applicable 2, Phase 3 4, Phase 2 4, Phase 1 1) 2008: 12 trials (Observational 1, Not applicable 2, Phase 3 2, Phase 2/3 1, Phase 2 5, Phase 1 1) 2009: 18 trials (Observational 1, Not applicable 5, Phase 3 5, Phase 2 6, Phase 1/2 1) 2010: 17 trials (Observational 6, Not applicable 1, Phase 3 4, Phase 2/3 2, Phase 2 4) 2011: 26 trials (Observational 3, Not applicable 7, Phase 3 8, Phase 2 8) 2012: 16 trials (Observational 1, Not applicable 3, Phase 3 6, Phase 2 6) 2013: 25 trials (Not applicable 8, Phase 3 5, Phase 2 10, Phase 1/2 1, Phase 1 1) 2014: 16 trials (Observational 3, Not applicable 4, Phase 3 3, Phase 2 6) 2015: 28 trials (Observational 2, Not applicable 5, Phase 3 12, Phase 2/3 3, Phase 2 4, Phase 1/2 1, Phase 1 1) 2016: 21 trials (Observational 2, Not applicable 4, Phase 3 5, Phase 2 5, Phase 1/2 2, Phase 1 3) 2017: 24 trials (Observational 3, Not applicable 2, Phase 3 8, Phase 2 7, Phase 1/2 3, Phase 1 1) 2018: 27 trials (Observational 2, Not applicable 5, Phase 3 9, Phase 2/3 1, Phase 2 5, Phase 1/2 5) 2019: 30 trials (Observational 2, Not applicable 4, Phase 4 1, Phase 3 7, Phase 2 11, Phase 1/2 4, Phase 1 1) 2020: 32 trials (Observational 6, Not applicable 3, Phase 3 11, Phase 2 8, Phase 1/2 3, Phase 1 1) 2021: 26 trials (Observational 4, Not applicable 3, Phase 3 6, Phase 2/3 1, Phase 2 11, Phase 1/2 1) 2022: 25 trials (Observational 5, Not applicable 2, Phase 4 1, Phase 3 8, Phase 2 7, Phase 1 2) 2023: 26 trials (Observational 2, Not applicable 7, Phase 3 5, Phase 2/3 1, Phase 2 7, Phase 1/2 4) 2024: 26 trials (Observational 2, Not applicable 7, Phase 3 10, Phase 2 5, Phase 1/2 1, Phase 1 1) 2025: 28 trials (Observational 2, Not applicable 5, Phase 4 1, Phase 3 11, Phase 2 9)

Trials that list this site and are registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 12
2025 28
2024 26
2023 26
2022 25
2021 26
2020 32
2019 30
2018 27
2017 24

Showing 10 of 32 years.

Start your 14-day trial Email me all 32 years as a PDF

2026 is partial: trials registered with a 2026 start date so far, not a full year. 1 trial is registered to start in 2027 or later, and not listed here

Recent trials

The newest registered trials that list this site. Each title opens its ClinicalTrials.gov record.

Showing 5 of 510 trials.

Start your 14-day trial Email me the first 50 trials as a PDF

Source: ClinicalTrials.gov

Lead sponsors

Most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Showing 5 of 73 lead sponsors.

Start your 14-day trial Email me the first 50 lead sponsors as a PDF

Conditions studied

The specific conditions of the trials that list this site, most trials first.

Showing 5 of 167 conditions.

Start your 14-day trial Email me the first 50 conditions as a PDF